Pure Global: Singapore's AI MedTech Scene - Inside the HSA's New Fast-Track Sandbox cover art

Pure Global: Singapore's AI MedTech Scene - Inside the HSA's New Fast-Track Sandbox

Pure Global: Singapore's AI MedTech Scene - Inside the HSA's New Fast-Track Sandbox

Listen for free

View show details

LIMITED TIME OFFER | Get 2 Months for ₹5/month

About this listen

 Singapore's Health Sciences Authority (HSA) has just launched a new fast-track regulatory sandbox for AI-powered medical devices. This pivotal move is set to accelerate the adoption of cutting-edge diagnostic and monitoring software, positioning Singapore as the premier gateway for digital health innovation in the ASEAN region. In this episode, we dissect what this new framework means for MedTech manufacturers. We explore the specific requirements companies must meet to qualify for the sandbox, the opportunities it unlocks for early market access, and the challenges related to data validation and post-market surveillance for adaptive AI algorithms. For years, AI MedTech developers faced a major hurdle: a regulatory system designed for hardware, not for software that learns and evolves. A groundbreaking AI diagnostic tool could spend years in regulatory limbo, unable to reach patients, while developers struggled to provide the right kind of evidence to authorities. This new sandbox directly addresses this pain point by creating a structured, yet accelerated, pathway for software as a medical device. Key questions answered in this episode: 1. What are the specific eligibility criteria for the HSA's new AI-SaMD sandbox? 2. How does this new pathway change the timeline for getting an AI medical device to market in Singapore? 3. What new types of evidence, especially for algorithm training and validation, are now required? 4. How can companies effectively manage post-market surveillance for an AI that is constantly learning? 5. Does this make Singapore the best market in ASEAN to launch a new digital health product? 6. What are the key cybersecurity and data privacy requirements that companies must meet? 7. How will the HSA handle version control and updates for approved AI algorithms? At Pure Global, we specialize in navigating complex regulatory landscapes. Our team combines local expertise with advanced AI tools to help MedTech innovators achieve market access in over 30 countries, including Singapore. From regulatory strategy and technical dossier submission to post-market surveillance, we offer end-to-end solutions. To streamline your entry into the ASEAN market, contact us at info@pureglobal.com or visit https://pureglobal.com/.
No reviews yet